Skip to main content
    T

    Tectonic Therapeutic, Inc. (TECX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $20.98
    -0.16 (-0.76%)

    Market Cap: $413.27M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Tectonic Therapeutic, Inc. (TECX) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Tectonic Therapeutic (TECX) to earn -$5.77 per share in the fiscal year ending Dec 31, 2026. Of 10 analysts, 9 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$4.76.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 10 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 90% of the ratings.

    RatingAnalystsShare
    Strong Buy110.0%
    Buy880.0%
    Hold110.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    10

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss.

    Fiscal year ending Dec 31, 2026
    -$5.77
    EPS consensus
    Fiscal year ending Dec 31, 2027
    -$4.76
    EPS consensus
    Next report
    Feb 24, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$5.77-$5.77 to -$5.771
    Dec 31, 2027-$4.76-$4.76 to -$4.761

    Quarterly Estimates

    The EPS consensus rises from -$1.42 for the quarter ending Dec 31, 2026 to -$1.30 for the quarter ending Mar 31, 2027.

    EPS range

    Quarter endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$1.42-$2.00 to -$0.9211
    Mar 31, 2027-$1.30-$1.55 to -$0.865

    Estimate Revisions

    No EPS estimate for the 3 periods below was revised in the last 30 days.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202600
    Fiscal year ending Dec 31, 202700
    Quarter ending Mar 31, 202700

    EPS Trend

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$5.77-$5.77N/AN/AN/AN/A
    Fiscal year ending Dec 31, 2027-$4.76-$4.76N/AN/AN/AN/A
    Quarter ending Mar 31, 2027-$1.30-$1.34-$1.34-$1.34-$1.34N/A

    Frequently Asked Questions About TECX

    What is the TECX stock forecast?

    Consensus analyst estimates put Tectonic Therapeutic's EPS at -$5.77 for the fiscal year ending Dec 31, 2026. The consensus rating from 10 analysts is Buy.

    How do analysts rate TECX stock?

    Of 10 analysts covering Tectonic Therapeutic, 1 rates it Strong Buy, 8 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from TECX next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$5.77, with estimates from -$5.77 to -$5.77 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$4.76, with estimates from -$4.76 to -$4.76 from 1 analyst.

    How many analysts cover TECX?

    10 analysts rate Tectonic Therapeutic stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.